serena williams on glp 1 SerenaWilliams is opening up about her experience with the GLP-1 drug Zepbound. The recent public discourse around Williams's body—online commenters have noticed a change in her physique and demanded to know how Why Serena Williams Went Public

Every path has its perks and pitfalls

doi: 10.1016/S0140-6736(21)01324-6 25 ArakiETanizawaYTanakaYTaniguchiAKoiwaiKKimGet al

This supports the recommendations in our supplements to take with GLP-1 medications guide

Clinical evidence shows patients who taper gradually over 812 weeks and maintain consistent exercise and protein intake retain 6075% of lost weight one year after discontinuation

For consumers, the take-home message is balanced: there is enough reassurance to support use in appropriate patients, but not enough reason to dismiss the warning entirely

While most other research focuses exclusively on current users or GLP-1 households, this report goes a step further by identifying not just what, but who is next